Number of the records: 1
levamizol
SYS d007978 LBL 00000nz--a2200000o--4500 005 20250606214316.2 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.886.675.346 065 $a D03.383.129.308.480 065 $a D03.383.129.708.346 066 $a 01 $c 03 150 $a levamizol $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Levotetramisole $2 eng 450 $w v $a L-Tetramisole $2 eng 550 $7 sllk_us_auth*d000276 $Y Adjuvants, Immunologic $w P $a adjuvanciá imunologické 550 $7 sllk_us_auth*d000969 $Y Antinematodal Agents $w P $a antinematodiká 550 $7 sllk_us_auth*d018501 $Y Antirheumatic Agents $w P $a antireumatiká 665 $a 74 $2 eng 680 9-
$i An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) $2 eng 750 -2
$a Levamisole $2 eng 980 $x M
Number of the records: 1